1997
DOI: 10.1097/00005373-199703000-00010
|View full text |Cite
|
Sign up to set email alerts
|

Pentoxifylline Maintains Hepatocellular Function and Improves Cardiac Performance during Early Sepsis

Abstract: Pentoxifylline appears to be a useful adjunct for maintaining hepatocellular function and improving cardiac performance during the early hyperdynamic stages of polymicrobial sepsis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

1997
1997
2015
2015

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 22 publications
0
12
0
Order By: Relevance
“…Pentoxifylline increases hepatic glutathione levels and reduces the production of oxygen radicals [61]. Additionally, pentoxifylline is well known to improve tissue oxygenation via its vasodilator effect and to restore hepatocellular function [62,63]. Therefore, these aforementioned findings could provide a number of auxiliary explanatory mechanisms for improvement of NAFLD and for decreasing both HA and TGF-b1 levels in NAFLD patients including patients with steatosis with or without inflammation and fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…Pentoxifylline increases hepatic glutathione levels and reduces the production of oxygen radicals [61]. Additionally, pentoxifylline is well known to improve tissue oxygenation via its vasodilator effect and to restore hepatocellular function [62,63]. Therefore, these aforementioned findings could provide a number of auxiliary explanatory mechanisms for improvement of NAFLD and for decreasing both HA and TGF-b1 levels in NAFLD patients including patients with steatosis with or without inflammation and fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…A PE-50 catheter in the right carotid artery was carefully advanced into the left ventricle. The position of the catheter was confirmed by restoring the analyzed form in an in vivo heart performance analyzer (Micro-Med) as described in our previous publications (34). Various left ventricular performance parameters, such as the maximal rate of the pressure increase (ϩdP/dt max ) and decrease (ϪdP/dt max ), were determined using a heart performance analyzer.…”
Section: Methodsmentioning
confidence: 99%
“…CBV was then calculated according to our previous publication [17]. Moreover, heart performance parameters such as the maximal rate of the left ventricular pressure increase (ϩdP/dt max ) and decrease (ϪdP/dt max ) were determined using a heart performance analyzer (Digit-Med, Louisville, KY) as reported [18].…”
Section: Methodsmentioning
confidence: 99%